These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Levodopa for the treatment of Parkinson's disease. Lewitt PA N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127 [No Abstract] [Full Text] [Related]
11. Does levodopa therapy delay death in Parkinson's disease? Uitti RJ; Ahlskog JE; Maraganore DM Mov Disord; 1996 May; 11(3):343-4. PubMed ID: 8723162 [No Abstract] [Full Text] [Related]
12. Inhibitors of dopamine inactivating systems as antiparkinson drugs. Youdim MB Adv Neurol; 1990; 53():483-8. PubMed ID: 2239488 [No Abstract] [Full Text] [Related]
13. Catechol-O-methyltransferase inhibitors: new options for Parkinson's disease. Leicht MJ; Mitchell SD S D J Med; 1999 Aug; 52(8):295-7. PubMed ID: 10453205 [No Abstract] [Full Text] [Related]
14. Drugs for Parkinson's disease. Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446 [No Abstract] [Full Text] [Related]
15. Ropinirole as compared with levodopa in Parkinson's disease. Hiner BC; Earnhart M N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684 [No Abstract] [Full Text] [Related]
16. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
17. Current controversies: levodopa in the treatment of Parkinson's disease. Sharma JC; Vassallo M; Ross IN Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129 [No Abstract] [Full Text] [Related]
18. Optimizing clinical outcomes in residents with Parkinson's disease. Introduction. Libow LS J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):3. PubMed ID: 17948615 [No Abstract] [Full Text] [Related]
19. Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? Martinelli P; Contin M; Scaglione C; Riva R; Albani F; Baruzzi A Neurol Sci; 2003 Oct; 24(3):192-3. PubMed ID: 14598082 [TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease. Second of two parts. Lang AE; Lozano AM N Engl J Med; 1998 Oct; 339(16):1130-43. PubMed ID: 9770561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]